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Abstract
Adhesion-GPCRs provide essential cell-cell and cell-matrix interactions in development, and have been implicated in
inherited human diseases like Usher Syndrome and bilateral frontoparietal polymicrogyria. They are the second largest
subfamily of seven-transmembrane spanning proteins in vertebrates, but the function of most of these receptors is still not
understood. The orphan Adhesion-GPCR GPR126 has recently been shown to play an essential role in the myelination of
peripheral nerves in zebrafish. In parallel, whole-genome association studies have implicated variation at the GPR126 locus
as a determinant of body height in the human population. The physiological function of GPR126 in mammals is still
unknown. We describe a targeted mutation of GPR126 in the mouse, and show that GPR126 is required for embryonic
viability and cardiovascular development.
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Introduction
Adhesion-GPCRs are the second largest subfamily of putatively
G-protein coupled receptors (GPCR) with more than 30 members
in mammals [1]. Their typical domain architecture consists of a C-
terminal seven-transmembrane spanning (7TM) domain homolo-
gous to secretin-like GPCRs, and a long N-terminal domain
containing a range of protein domains found in cell adhesion
proteins [2]. N- and C-terminal domains can be autocatalytically
cleaved at the membrane-proximal GPS (GPCR proteolytic site)
domain, which is a characteristic feature of this receptor class [3].
The biological function of most Adhesion-GPCRs is still
unknown. Mutations in some members of the protein family have
been identified as the cause of inherited developmental defects in
humans like Usher Syndrome (VLGR1) [4] and bilateral
frontoparietal polymicrogyria (GPR56) [5]. The cadherin-like
Adhesion-GPCR flamingo (alternative names: stan (starry night);
CELSR (cadherin, EGF-like, LAG-like, and seven-pass receptor))
has been implicated in planar cell polarity in Drosophila [6,7] and
axonal tract development in mice [8]. We have recently shown
that a highly conserved Adhesion-GPCR, the Latrophilin homolog
lat-1, is essential for tissue polarity in the C. elegans embryo [9].
Although there is no consensus yet about the physiological
function of Adhesion-GPCRs and their molecular mechanism of
signalling, the existing data suggest that this receptor class
mediates essential cell-cell and cell-matrix interactions [2].
Recently, an orphan receptor of the Adhesion-GPCR family,
GPR126, has been shown to play an essential role in the
myelination of peripheral nerves by neural crest (NC) -derived
Schwann cells in the zebrafish Danio rerio [10]. Schwann cells
lacking GPR126 expression fail to to a myelinate their target
axons, suggesting that GPR126 is a key component of the elusive
signalling pathway by which axons communicate with the
myelinating cell [11,12].
In mammals, GPR126 has been described as an orphan
receptor with a tightly regulated expression pattern in mouse
development (DREG) [13], and has also been isolated from
human umbilical vein endothelial cell (HUVEC) cultures (vascular
inducible GPCR, VIGR) [14]. Surprisingly, whole-genome
association studies have identified genetic variation at the
GPR126 locus as a determinant of trunk length and body height
in the human population [15,16,17]. The physiological function of
GPR126 in mammals is unknown, and there is currently no model
that could explain the molecular mechanism of this trait.
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We describe here a targeted mutation of GPR126 in the mouse
and show that the receptor is required for embryonic viability and
cardiovascular development.
Results
GPR126 is an evolutionary innovation specific for
vertebrates
The GPR126 locus is highly conserved in vertebrates. We could
identify putative genes encoding homologous proteins with the
typical domain architecture (CUB, Laminin G/Pentaxin, GPS,
7TM2, Fig. 1a) in all vertebrate species that were investigated. The
synteny of the genomic region surrounding these genes is
conserved in fish, birds, reptiles, and mammals, indicating that
the predicted genes are true orthologues (Fig. 1b). A GPR126
homologue is also present in the amphibian Xenopus tropicalis, but
although synteny also appears to be conserved a comprehensive
annotation is currently not possible due to the fragmentation of
sequence contigs.
The genomes of the sea urchin S. purpuratus and of Trichoplax
adherens are predicted to encode Adhesion-GPCRs with N-termini
containing a CUB domain in conjunction with EGF or Ig-like
domains, respectively. Thus, the domain architectures of these
putative receptors are clearly divergent from vertebrate GPR126.
No orthologues of GPR126 were found in the high quality
genomes of the chordates Ciona intestinalis, C. savignyi and
Branchiostoma floridae, or in the draft genome assembly of the
lamprey Petromyzon marinus.
These results indicate that GPR126 is specific for vertebrates.
This would be consistent with the proposed function in Schwann
cell precursors (SCP) [10] which originate from the NC. The NC
is considered to be a developmental innovation that is unique to
vertebrates [18].
The closest paralog of GPR126 is GPR112, which also appears
to be specific for vertebrates (Fig. 1a). In mammals, GPR112 is
located on the X chromosome and contains a long (.1500 amino
acids) domain in its N-terminus predicted to be an extended coil
structure. This domain is not present in GPR126. In zebrafish,
GPR112 is located on Chromosome 10, is lacking the coil domain,
and is highly similar to zebrafish GPR126 (Chr. 20, amino acid
identity 30%, similarity 48%, Figure S1).
A targeted mutation of GPR126 expressing a LacZ
reporter gene
To follow the expression pattern of GPR126 in detail and to
identify its physiological function we generated a targeted mutation
in murine embryonic stem cells which disrupts the GPR126 coding
region and expresses a LacZ reporter gene under the control of the
GPR126 promotor (GPR126LacZ). The sequences encoding part of
the 7TM domain were deleted (Fig. 1a), and a LacZ reporter gene
cassette [19] was inserted into the locus (Fig. 2a, b).
Heterozygous GPR126LacZ/+ carriers were born at the
expected Mendelian frequency (Table 1) and did not show any
obvious phenotypes, indicating that the targeted locus does not
have detrimental dominant activity. Wild-type GPR126 transcript
could not be detected in homozygous embryos (see below),
suggesting that the targeted allele is a null mutation (Fig. 2c).
Dynamic segmental expression of GPR126 in the embryo
We investigated the expression pattern of the wild-type GPR126
gene in adult tissues by RT-PCR, in situ hybridization (ISH), and
immunofluorescence staining (IF). Our PCR analysis confirmed
that GPR126 mRNA is widely expressed (Figure S2) [13].
However, in spite of substantial efforts we were not able to
reproducibly detect the wild-type gene product on a cellular level
by ISH or IF.
In heterozygous GPR126LacZ/+ embryos, no reporter gene
expression was seen up to 9.5 dpf (days post fertilisation). At 10.5
dpf a weak segmental expression is consistently observed in trunk
and tail (Fig. 3 a, g) [13]. This pattern becomes more pronounced
at 11.5 dpf, and rapidly fades at 12.5 dpf (Fig. 3 c, h–j). Sectioning
of embryos shows the expression in close proximity to the somitic
myotome, but very little lacZ expression overlaps with cells
positive for a myotome marker a-smooth muscle actin (a-SMA)
(Fig. 4 a, b, d, e, g, h). Notably, expression of GPR126 in each
segment is restricted to very few cells in a dispersed ‘‘salt-and-
pepper’’ fashion (Fig. 3 g, 4b). The time course of expression
observed in our study is slightly delayed compared to the ISH data
reported earlier [13]. This most likely reflects the time required for
expression and maturation of the reporter protein.
The pattern in the embryo is consistent with a very dynamic
expression in a small subset of neural crest derived cells in trunk
and tail. The typical locations of the cranial neural crest and the
branchial arches including cardiac neural crest are negative for
reporter expression. We also detected expression of GPR126LacZ
in the trophoblast giant cells (TGC) of the placenta (Fig. 5).
We were not able to detect clear and reproducible expression in
the CNS, branchial arches and cephalic mesenchyme, the heart,
vasculature, or other organ primordia of GPR126LacZ/+ embryos.
Analysis of specimens from adult heterozygous transgenics also did
not reveal distinct expression patterns of GPR126 in mature
tissues. We were not able to detect a staining pattern equivalent to
the expression in SCP in Zebrafish [10].
Loss of GPR126 function leads to mid-gestation lethality
No homozygous offspring are born from matings of heterozy-
gous carriers, indicating embryonic lethality (Table 1, 2). The
genotypes of dissected embryos show that a sharp loss of viability
occurs from 10.5 dpf to 12.5 dpf, consistent with the onset of intra-
embryonic expression. At 11.5 dpf more than 50% (23/43) and at
12.5 dpf 80% (12/15) of the homozygous embryos are dead. No
viable embryos were recovered at 13.5 dpf (Table 2).
Mutant embryos show no obvious malformations and somite
numbers are indistinguishable from controls, indicating that
development is not significantly delayed at 10 dpf and 11 dpf
(not shown). We did not detect abnormalities in the histological
architecture of the placenta of homozygous embryos or changes in
the distribution of TGC (Fig. 5). Thus, we could not find evidence
for defects in placental development or function.
The number and distribution of cells expressing the
GPR126LacZ reporter gene is changed in homozygous embryos.
An increased number of LacZ-positive cells are clustered in a
narrow extension of the normal expression domain (Fig. 3 d–f, l).
Histological sections confirm the presence of a larger number of
LacZ-positive cells in the somitic domain, and again indicate that
only a minority of these co-express a-SMA (Fig. 4 c, f, i). This
observation would be consistent with a complete or partial block in
the differentiation and/or migration of a GPR126-expressing cell
population, leading to an accumulation of cells that might be
delayed or stalled on their path of migration.
Cardiovascular failure in GPR126 mutants
Viable homozygotes with beating hearts are regularly found in
the same litter next to dead embryos showing signs of circulatory
failure like congestion, edema, and internal hemorrhage. This
suggests that cardiovascular function in mutants is initiated
normally and fails within 24–48 hrs after the onset of GPR126
expression.
GPR126 Knockout Mouse
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Figure 1. The domain architecture and genomic conservation of GPR126. a. The domain architecture of GPR126 in comparison to other
Adhesion-GPCRs. Sketches are drawn to scale of primary protein structure, the conserved domains of the N-terminus are colour-coded. The shaded
box in mouse GPR126 depicts the region deleted in the targeted allele GPR126LacZ. The arrow in zebrafish GPR126 shows the point of truncation in
gpr126(st49) [10]. The closest homolog of GPR126 is GPR112, which shares the Pentaxin domain but lacks the CUB domain. In zebrafish, GPR126 and
GPR112 are structurally more similar than in mammals, where GPR112 contains a very long coiled domain in its N-terminus. CUB: C1r/C1s, Uegf, Bmp1
domain; EGF: Epidermal Growth Factor domain; HRM: Hormone-binding motif. b. Schematic depiction of the conserved synteny surrounding the
GPR126 locus in diverse vertebrate species. Note that the synteny of the zebrafish locus is highly conserved to reptiles, birds, and mammals, while
other fish species show higher divergence. NMBR: neuromedin B receptor; GJE-1: gap junction protein epsilon 1 (pseudogene gje-1 in humans); VTA-1
Vps20-associated 1 homolog (S. cerevisiae); HIVEP-2: HIV enhancer binding protein 2; AIG-1: androgen-induced gene 1; E2F6: E2F transcription factor
6; MSRA: methionine sulfoxide reductase A; ASAP2; ArfGAP with SH3 domain, ankyrin repeat and PH domain 2; ITGB1BP1: integrin beta 1 binding
protein 1: EDN-1; endothelin 1; NACHT: NACHT-NTPase containing protein; KIAA1737: unknown novel protein; ZNF410: zinc-finger protein 410.
doi:10.1371/journal.pone.0014047.g001
GPR126 Knockout Mouse
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In wild-type embryos, crucial steps of cardiac development like
septation and the formation of the outflow tract are only
completed after 12.5 dpf. As embryos homozygous for the
GPR126LacZ allele die before this time point it is difficult to
distinguish primary defects in heart development from secondary
effects of circulatory failure due to other reasons. Expression of
GPR126 could not be detected in typical cardiac neural crest
(CNC) locations [20], and histological analysis indicates that
septation and the formation of the CNC-derived outflow tract are
initiated normally (Fig. 6).
The development of the ventricular wall is not obviously
defective at 10.5 dpf, and myocardial trabeculation is formed. In
homozygous mutant embryos that still showed active circulation at
the time of dissection we could not detect an obvious reduction of
myocardial tissue or a lack of trabeculation. However, in embryos
that were dissected after onset of circulatory failure we found a
pronounced thinning of the myocardial wall (Fig. 6c, d). This
suggests that ventricular function is initially normal and might fail
under increased load.
In heterozygous carriers of the GPR126LacZ allele reporter gene
expression in the ventricular wall can hardly be detected above
background levels. However, the examination of myocardial tissue
from homozygous mutants revealed a dispersed population of cells
with a very low but reproducible level of LacZ expression (Fig. 6e).
This suggests the presence of a GPR126-expressing cell population
in myocardial tissue, and provides a possible rationale for cardiac
failure in mutants. Counterstaining established that as in the
somite only a subset of LacZ positive cells also show a-SMA
expression, while no overlap could be detected with the
endothelial marker PECAM (Fig. 6 f–h).
The difference in myocardial lacZ staining between heterozy-
gotes and homozygotes could be due to the increased gene dosage
in homozygotes, or due to an accumulation of lacZ positive cells in
mutants. Due to the very low staining intensity the resolution of
this question will require additional transgenic reagents, e.g.
permanent marking of GPR126-positive cells by site-directed
recombination [21,22].
Vascular development in GPR126 mutants
GPR126 was initially isolated from HUVEC cultures that had
been challenged with lipopolysaccharides or thrombin [14] and
Figure 2. Disruption of the mouse GPR126 gene by homologous recombination in embryonic stem cells. a. Schematic depiction of the
wild-type GPR126 locus, the targeting vector, and the targeted locus after homologous recombination. Numbered boxes represent GPR126 coding
exons 15–19, LacZ reporter and neomycin-resistance gene expression cassettes are shown as shaded boxes. KpnI, and BglII restriction enzymes sites
as used in b. Arrows depict PCR primers used in c. b. Southern blot showing correct targeting of the GPR126 locus in embryonic stem cells, using the
hybridization probe shown in a. Correct integration creates a new KpnI fragment of ,6 kb and increases the size of the BglII fragment to , 12 kb. c.
PCR analysis demonstrating the absence of GPR126 transcript (top row) and the deletion of the GPR126 genomic locus (bottom row). HPRT transcript
was used as a control for cDNA concentration in RT-PCR. The genomic PCR used three primers to amplify the wild-type and mutant fragments in a
single reaction. +/+; wild-type samples; +/2: heterozygote samples; 2/2: homozygous mutant samples.
doi:10.1371/journal.pone.0014047.g002
Table 1. Live offspring from GPR126LacZ matings.
Stage Cross +/+ +/2 2/2 N
genotypes n % n % n %
weanlings +/2 x wt 186 49.3% 191 50.7% n/a 377
weanlings +/2 x +/2 10 32.3% 21 67.7% 0 0.0% 31
Intercrosses of animals heterozygous for GPR126LacZ do not produce liveborn
homozygous offspring.
doi:10.1371/journal.pone.0014047.t001
GPR126 Knockout Mouse
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was implicated in endothelial cell function. We observed intra-
embryonic hemorrhage in ,50% (24/49) of GPR126LacZ
embryos that were found dead at dissection, and therefore
investigated defects in vascular development as a possible cause
of lethality. Immuno-histochemical detection of the endothelial
marker PECAM-1 in whole-mount embryos and in histological
sections did not reveal any consistent defects of angiogenesis or
vasculogenesis in mutant embryos (Fig. 7). We could not detect co-
expression of GPR126LacZ and PECAM, indicating that the
expression level is below the detection limit in unchallenged
endothelial cells.
The development of endothelium in large and small vessels
(Fig. 7 a, b, e, f) and the complexity of the vascular tree (Fig. 7 c, d)
are not significantly different between homozygous mutants and
controls. No abnormalities were detected in placental vessels and
umbilical cord. The paired dorsal aortae develop and fuse
normally (Fig. 7 g, h), and the vascular wall is stabilised by the
recruitment of smooth muscle cells (Fig. 7 i, j) and extracellular
matrix. Hematopoietic clusters in mutant vessels also develop at
the correct time and localisation (not shown). Thus, in spite of the
reported expression of GPR126 in endothelial cell cultures we
could not detect expression of GPR126 in endothelia in vivo, and
were not able to find evidence supporting a defect of vascular
development as the cause of embryonic lethality.
Discussion
We describe the first genetic analysis of GPR126 function in a
mammalian model. The targeted mutation GPR126LacZ deletes
part of the 7TM region (Fig. 1a) and is presumably a null allele.
Residual wild-type transcripts could not be detected in mutant
embryos, and a truncation of the related receptor lat-1 has been
shown to lack residual function in C. elegans [9,23].
Homozygous mutant embryos show fully penetrant lethality due to
cardiovascular failure at mid-gestation. Lethality coincides with the
expression of GPR126LacZ in a small group of cells in trunk and tail
somites, but due to the very low and transient levels of gene expression
we could not directly determine which anatomical structures are
ultimately derived from this cell population. We did not find evidence
for developmental defects of the vascular system, the cardiac neural
crest, or the placenta, and suggest that GPR126 is required for the
development and/or the function of nascent myocardial tissue.
Figure 3. The expression pattern of the GPR126LacZ reporter allele. Expression pattern of GPR126. Embryos carrying the GPR126LacZ allele
were stained for b-galactosidase activity as whole-mount preparations. Heterozygous (a–c) and homozygous (d–f) embryos at 10.5, 11.5, and 12.5 dpf,
respectively. (g–j): higher magnification view of expression in somitic region in a heterozygous embryo. Note the faint and transient expression. (k, l):
comparison of heterozygous and homozygous embryo at 11.5 dpf. Note the change in expression pattern and intensity in the homozygous
specimen. Scalebar (a–f) 2 mm, (g–l) 500 mm.
doi:10.1371/journal.pone.0014047.g003
GPR126 Knockout Mouse
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Expression of human GPR126 has been reported in vitro in
HUVEC cultures stimulated by lipopolysaccharide (LPS) [14].
However, we could not detect GPR126LacZ in embryonic
endothelia in vivo and did not observe morphological abnormalities
of the developing vascular system. A defect of the cardiac neural
crest in GPR126 mutants also appears unlikely. Firstly, CNC cells
migrate via the branchial arches [24], where GPR126LacZ is not
expressed. Secondly, the development of the cardiac outflow tract
is initiated normally in GPR126 homozygotes. Thirdly, mice with
severe disruption of CNC development, e.g. Splotch mutants, show
malformation of the outflow tract by 13.5 dpf and embryonic
death by 14.5 dpf [24], significantly later than GPR126 mutants.
This strongly suggests that abnormal development of the CNC
would not be sufficient to explain the phenotype of GPR126LacZ
homozygotes.
Although GPR126 is expressed in TGC, the histological
architecture of the placenta is normal in GPR126 homozygotes.
Embryonic development up to 11 dpf is not delayed, arguing
against a significant impairment of placental function. We could
not find precedents in the literature where a functional defect in a
morphologically normal placenta causes fully penetrant lethality in
a narrow time window at 11.5–12.5 dpf, as observed in GPR126
mutants. The lethality profile is the same on inbred and outbred
genetic backgrounds, indicating that a loss of immune privilege is
not a likely cause of embryonic death. In future experiments, the
role of GPR126 in the placenta could be directly tested by creating
chimeras of homozygous GPR126 embryos with tetraploid wild-
type embryos.
Weakly LacZ-positive cells were observed in the ventricular wall
of GPR126LacZ homozygotes, suggesting that GPR126 might have
a function in myocardial development. In GPR126 mutants the
myocardial wall is thinned, but shows no defect in trabeculation.
Thus, a defect in the development of the ventricle wall of the heart
appears to be the most likely cause of death in GPR126 mutants.
In contrast to the embryonic lethality in GPR126LacZ mice,
zebrafish homozygous for the gpr126(st49) allele develop into fertile
adults with a defect in Schwann cell function [10]. The predicted
products of GPR126LacZ and gpr126(st49) are similar (Fig. 1a) [10],
arguing against an allele-specific effect. Due to the early
embryonic lethality we could not investigate the role of GPR126
in mouse SCP and myelin sheath formation. However, it is
unlikely that a defect in SCP causes lethality in GPR126LacZ mice,
as other mutants lacking SCP develop to term [25].
Our results indicate that GPR126 has an essential function in
mammalian development that has not been predicted by the
analysis of GPR126 mutations in Zebrafish. This could either be
due to true differences in the developmental pathways of fish and
mammals, or due to different levels of functional redundancy and
compensation by other members of the Adhesion-GPCR family.
A link between heart morphogenesis and Schwann cell
development is demonstrated in mice mutant for components of
the neuregulin/erbB2-4 pathway, which display a syndrome of
myocardial failure and defects in SCPs [26,27,28]. In zebrafish,
the mutant phenotypes are milder with respect to embryonic
lethality, presumably due to the existence of additional paralogs,
e.g. two copies of erbB3 (erbB3a and erbB3b [29,30]). This
suggests that the underlying developmental pathways are similar
between fish and mammals, and that partial genomic redundancy
is the cause of phenotypic differences.
The conserved synteny at the GPR126 locus clearly indicates
that mouse and zebrafish GPR126 are true orthologs. We could
not detect an additional copy of GPR126 in the zebrafish genome
which could explain the milder phenotype of the gpr126(st49)
allele. However, the most closely related Adhesion-GPCR,
GPR112, shows much higher homology to GPR126 in fish than
in mammals (Fig. 1a). This suggests that in zebrafish a partial
redundancy between GPR126 and GPR112 might ameliorate the
phenotype of GPR126 mutants. Experimentally this could be
tested by knockdown of GPR112 in gpr126(st49) mutants.
Conditional inactivation of the erbB2 pathway in adult mice
leads to dilated cardiomyopathy and has been linked to the
cardiotoxicity of the therapeutic antibody trastuzumab (Hercep-
tinH) [31]. Our results strongly suggest that any therapeutic
intervention targeting GPR126, e.g. to modulate myelination, will
require careful consideration of cardiac side effects.
Due to the very restricted and transient expression of GPR126,
a limitation of our study has been the difficulty to characterise the
origin and fate of GPR126-positive cells. We consider it unlikely
that standard ISH and IF will be able to fully resolve this problem.
The further analysis of GPR126 function will require the
identification of the tissues formed by GPR126-positive cells by
permanent transgenic marking, e.g. by constitutive activation of a
LacZ reporter gene by a GPR126-Cre transgene [21,22], the use
of tissue specific conditional mutagenesis, and the analysis of
chimeric embryos.
Figure 4. Expression of GPR126LacZ in the somite. GPR126 is
expressed in the somite. Heterozygous (a, b, d, e, g, h) and GPR126 null
(c, f, i) embryos at 10.5 dpf were stained as whole-mount specimens for
b-galactosidase activity to visualise GPR126 expression. Transverse
cryostat sections of 20 mm thickness were then counter-stained with an
a-SMA antibody. Note the interspersed expression of GPR126 and a-
SMA with few double-positive cells. Overlay images (g–j) have been
post-processed electronically to enhance visualisation. Scale-
bar = 50 mm.
doi:10.1371/journal.pone.0014047.g004
GPR126 Knockout Mouse
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Figure 5. GPR126 is expressed in the placenta. Gpr126 is expressed in trophoblast giant cells, but the anatomy of the placenta is normal in
GPR126LacZ homozygotes. 2 mm vibratome sections of placentas from wild-type, heterozygous and GPR126 null embryos at e10 and e11 were
stained with X-Gal to visualise GPR126LacZ expression, cryosectioned at 20 mm and counterstained with Nuclear Fast Red. TGC - trophoblast giant
cells, Sp - spongiotrophoblast, Lab - labyrinth. Scalebar = 100 mm.
doi:10.1371/journal.pone.0014047.g005
Table 2. Embryonic genotypes derived from GPR126LacZ matings.
Stage Cross +/+ +/2 2/2 resorption N
dpf genotypes n(dead) % n(dead) % n(dead) % n %
9.5 +/2 x +/2 15 23.4% 33 51.6% 14 21.9% 2 3.1% 64
10.5 +/2 x +/2 50 24.5% 104 51.0% 35 17.2% 15 7.4% 204
11.5 +/2 x +/2 51(3) 23.6% 95(4) 44.0% 43(23) 19.9% 27 12.5% 87
12.5 +/2 x +/2 25(0) 22.1% 64(1) 56.6% 15(12) 13.3% 9 8.0% 87
13.5 +/2 x +/2 19(0) 21.8% 48(2) 55.2% 2(2) 2.3% 18 20.7% 87
Genotyping of embryos dissected after timed matings reveals a sharp loss of homozygous offspring from 10.5 dpf onwards.
doi:10.1371/journal.pone.0014047.t002
GPR126 Knockout Mouse
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Genetic variation at the GPR126 locus is linked to the
heritability of height in the human population [15,16,17]. The
molecular nature of different GPR126 alleles is not known.
GPR126 contributes specifically to trunk length rather than limb
length, consistent with our finding that the gene is expressed in a
segmental pattern in a putative migratory cell population. While
our findings cannot explain the role of GPR126 polymorphisms in
humans, they might guide further mechanistic studies.
Materials and Methods
Ethics statement
All procedures were carried out in accordance with the Animals
(Scientific Procedures) Act 1986 and with the approval of local
ethical review committees under the UK Home Office Project
License PPL 30/2462.
Comparative genomic analysis
Genomic loci and predicted gene products for GPR126 were
obtained from the Ensembl database (http://www.ensembl.org)
and analysed with the Geneious software package (Biomatters
Ltd., Auckland, NZ). The zebrafish GPR112 locus was identified
by GNOMON annotation of the genomic scaffold 1269 (Zv8,
NCBI Acc NW_001877055) on Chr. 10. The predicted mRNA
and protein are available under NCBI Acc XM_002663550 and
XP_002663596, and are supported by EST evidence.
Analysis of RNA expression
Embryos were dissected from the uterus, the yolk sac and
amnion removed, and the embryo and placenta separated.
Embryos were minced on ice in sterile phosphate buffered saline
(PBS) and stored in RNALater at 220uC. Tissues and embryos
were homogenised in a ground glass homogeniser and total RNA
was isolated with Trizol reagent (Invitrogen) according to
manufacturer’s protocol. First strand cDNA was synthesized with
Superscript III reverse transcriptase (Invitrogen) using random
hexamer primers (Promega).
RT-PCR was performed according to standard protocols.
Relative cDNA levels were determined by PCR for Hypoxan-
thine-guanine phosphoribosyltransferase (Hprt) and b-actin. The
primer sequences are: mGPR126: 59-CTTGTCCTGTCCAA-
TCCTTCCGGT-39, 59-TCCACCGCTATAT TCTAAAAT-
TCTG-39, 59-CAGCAACTCTGATGTAGCTGGCGT-39, and
59-GGTCAGTTTTGA CAGGGACTTG-39; HPRT: 59-ACT-
TGCTCGAGATGTCATGAAGG-39 and 59-CCTGTATCCAA
CACTTCGAGAGGT-39; b-actin: 59-GCCCAGAGCAAGAG-
AGG TATCCT-39, and 59-CGTCTC CGGAGTCCATCA-
CAA-39.
Generation of the GPR126LacZ allele
For timed matings, females were housed with stud males and
checked for vaginal plugs each morning, with the morning of plug
discovery taken as embryonic day 0.5 (0.5 dpf).
The vector for homologous recombination was constructed as
described previously [19,32]. Homology arms of 3924 bp (59) and
1256 bp (39) were generated by PCR and inserted into a targeting
vector providing the reporter gene and the positive and negative
selection cassettes. In the targeted locus, most of exon 18 is deleted
and replaced by a 4.5 kb fragment containing the IRES-LacZ-
neoR cassette, resulting in a truncation of GPR126 at residue 830
immediately N-terminal of the first transmembrane helix.
The vector was electroporated into the CCB embryonic stem
cell line, and correctly targeted clones identified by southern
blotting and PCR. The targeted allele GPR126LacZ was
transmitted through the germ line and maintained on inbred
129SvEv and outbred MF1 backgrounds, as well as back-crossed
to C57B/6 for 10 generations. Mice and embryos were genotyped
by PCR with internal control. A common reverse primer binds
wild-type and targeted alleles, while forward primers bind the
neomycin resistance cassette or wild-type mGPR126 sequence
located 59 to the b-galactosidase/neomycin cassette yielding
products of 180 bp or 266 bp respectively. DNA was extracted
from ear-biopsies or yolk-sacs, and PCR was performed with the
primers 59-ATGAGAAACATGAGGATTAAAGGGGA-39, 59-
Figure 6. The heart phenotype of GPR126LacZ mutants. (a–d) GPR126LacZ mutants show dilation of the heart ventricle. Histological sections
through the heart of heterozygous (a, b) and homozygous (c, d) specimens at 11.5 dpf, H&E stain. (b) and (d) are higher magnification views of the
boxed area in (a) and (c). Note the thinning of the ventricular wall in (d) compared to (b) (arrows) and the presence of myocardial trabeculation.
Scalebar = 100 mm. (e–h) GPR126LacZ is weakly expressed in embryonic heart. Homozygous embryos at 11.5 dpf were stained for b-galactosidase
activity as whole-mount specimens to visualise GPR126 expression (e), cryosectioned at 20 mm and counter-stained with an a-SMA (f) or a- PECAM (h)
antibodies. In (g) the a-SMA in green is overlayed with the lacZ signal of (e) false-coloured in red, showing little overlap between the two channels.
The panels (e) and (g) were post-processed electronically to enhance the visualisation of the very weak lacZ signal.
doi:10.1371/journal.pone.0014047.g006
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GGATCTTCCAAGGAGTGCCTCAC AA-39 for mGPR126,
and 59- GCAGCGCATCGCCTTCTATC-39 for the neomycin
resistance cassette.
Whole-mount embryo staining
Histochemical staining for LacZ reporter gene activity was
performed as described [19]. Adult tissues or embryos dissected
after timed matings were washed twice for 5 min in PBS
containing 2 mM magnesium chloride, fixed at 4uC in 0.2% (v/v)
glutaraldehyde, 100 mM phosphate buffer pH 7.4, 5 mM EGTA,
2 mM magnesium chloride, and washed three times for 5 min at
room temperature in LacZWash Buffer (100 mM phosphate buffer
pH 7.4, 0.01% (v/v) Nonidet P-40, 0.02% (w/v) sodium deoxy-
cholate, 2 mM magnesium chloride). Embryos and tissues were
incubated for 15–48 h in LacZ stain (0.8–1.6 mg/ml X-Gal,
100 mM phosphate buffer pH 7.4, 0.01% (v/v) Nonidet P-40,
0.02% (w/v) sodium deoxycholate, 5 mM potassium ferricyanide,
5 mM potassium ferrocyanide, 2 mMmagnesium chloride) at 37uC
in the dark. Samples were post-fixed in 4% (w/v) paraformaldehyde
in PBS and Histology.
For whole-mount immunohistochemistry, embryos were stained
with primary antibodies against PECAM and aSMA (rat anti-
mouse PECAM clone MEC13 (BD Pharmingen) at a 1 in 200
dilution and mouse anti-human aSMA clone 1A4 (Dako) at a 1 in
500 dilution) and HRP conjugated secondary antibodies against
rat and mouse (goat anti-rat IgG (Stratech) at a 1 in 100 dilution
and goat anti-mouse IgG (Millipore) at a 1 in 100 dilution).
Embryos were fixed in 4% (w/v) paraformaldehyde in PBS,
dehydrated through a series (25%, 50%, 75%, 100%, 100% (v/v))
of methanol in PBS, and stored at 220uC.
Specimens were bleached in 6% (v/v) hydrogen peroxide in
methanol for 5 h 30 min on a shaking platform, rehydrated
through a series (100%, 75%, 50%, 25% (v/v)) of methanol in
PBS, permeabilised in PBS containing 0.1% (v/v) Triton X-100,
and blocked in blocking solution (PBS containing 2% (w/v)
Marvel skimmed milk powder and 0.1% (v/v) Triton X-100) for
1 h before incubation in rat anti-mouse PECAM clone MEC13
primary antibody (BD Pharmingen) at a 1 in 200 dilution in
blocking solution. Specimens were then incubated twice in
blocking solution for 1 h at 4uC and three times for 1 h at room
temperature before incubation in HRP conjugated goat anti-rat
IgG secondary antibody (Stratech) at a 1 in 100 dilution in
blocking solution overnight at 4uC. After further incubations in
blocking solution for 1 h at 4uC and three times for 1 h at room
temperature before further blocking in PBS containing 0.2% (w/v)
bovine serum albumin and 0.1% (v/v) Triton X-100, once for
10 min at room temperature, once for 40 min at room
temperature, the stain was developed with PBS containing
0.5 mg/ml DAB, 2 mg/ml ammonium nickel sulphate and
0.003% (v/v) hydrogen peroxide for 2–10 min.
Histology
For frozen sections, samples were cryoprotected in 30% (w/v)
sucrose in PBS and embedded in TissueTek (Bayer). 10–20 mm
sections were taken using a Bright 5040 cryostat. For paraffin-
embedded sections, 6 mm sections were taken on a Leica DSC1
microtome and mounted onto X-tra adhesive slides (Surgipath).
Haematoxylin/eosin staining was performed according to stan-
dard protocols.
Immunohistochemistry was performed according to standard
protocols with the primary antibodies a-GPR126 (Abcam) 1:50,
1:100 and 1:500 dilution, a-PECAM (platelet and endothelial cell
adhesion molecule) clone MEC13 (BD Pharmingen) 1:200
dilution, a-smooth muscle actin (aSMA) clone 1A4 (Dako) 1:500
dilution. Signal was detected with secondary antibodies conjugated
to horseradish peroxidase (goat anti-rabbit IgG (Millipore), goat
anti-rat IgG (Stratech), horse anti-mouse IgG (Vector Laborato-
ries)), or a fluorophore (Alexa Fluor 488 conjugated goat anti-
mouse IgG (Invitrogen), all in 1:100 dilution. Sections were
counterstained with Nuclear Fast Red or Haematoxylin and
mounted using Vectamount or Vectashield (Vector Laboratories).
Microscopy
Histological sections were visualised with a Zeiss Axioplan2.0
microscope fitted with an AxioCam HD camera. Whole-mount
samples were documented with a Nikon SMZ1500 dissection
microscope fitted with a Leica DC500 camera. Images were
collected and manipulated using Adobe Photoshop 9.0.
Figure 7. The developing vasculature in GPR126LacZ embryos.
Patterning of blood vessels is normal in GPR126LacZ embryos. Wild-type
(a, c, e, g, i) and homozygous GPR126LacZ (b, d, f, h, j) embryos at 10.5
dpf were stained as whole-mount specimens with an a-PECAM (a–h) or
a-SMA (i, j) antibodies. (a, b) Overall patterning of the vasculature is not
disrupted in mutant embryos. (c, d) The complexity of branching of
cranial vessels is normal, as is the development of intersomitic
vasculature (e, f). (g, h) The dorsal aortae form normally and smooth
muscle cells are recruited to stabilize the vessels (i, j). Scalebar1 mm (a,
b) 200 mm (e, f) and 50 mm (g–j).
doi:10.1371/journal.pone.0014047.g007
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Supporting Information
Figure S1 Alignment of zebrafish GPR126 and GPR112,
showing the high degree of homology between the paralogs.
Found at: doi:10.1371/journal.pone.0014047.s001 (0.66 MB TIF)
Figure S2 Expression of Gpr126 in adult tissues. cDNA was
amplified from wild-type mouse organs using gene specific primers
against Gpr126. b-Actin was amplified as positive control to
normalize cDNA concentration (b-Actin + RT (reverse transcrip-
tase)). b-Actin -RT: reaction without reverse transcriptase as
control for genomic DNA contamination. Expected band sizes:
Gpr126 759bp, b-Actin 303bp.
Found at: doi:10.1371/journal.pone.0014047.s002 (0.79 MB TIF)
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